DOSSIER · 13F Holders · Q1 2026Healthcare · Biological Products, (No Diagnostic Substances)Mega-capCrowded
IBRX
IMMUNITYBIO INC
400 institutions still hold IMMUNITYBIO INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 45256X103·Biological Products, (No Diagnostic Substances)·400 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
400 institutions reported IBRX in Q1 2026. BlackRock, Inc. leads at 19.9% of the visible book. +44 net new institutions vs prior quarter — accumulation reading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 20
380 more holders available. Log in →